(Q43597730)

25 November 2017

title

Trends in frequency and susceptibilities of Candida glabrata bloodstream isolates at a university hospital (English)

1 reference

25 November 2017

0 references

Baddley JW

1

1 reference

25 November 2017

Smith AM

series ordinal

2

1 reference

25 November 2017

Moser SA

series ordinal

3

1 reference

25 November 2017

Pappas PG

series ordinal

4

1 reference

25 November 2017

publication date

1 March 2001

1 reference

Diagnostic Microbiology and Infectious Disease

25 November 2017

published in

1 reference

25 November 2017

volume

39

1 reference

25 November 2017

issue

3

1 reference

25 November 2017

page(s)

199-201

1 reference

The epidemiology of hematogenous candidiasis caused by different Candida species

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900214-0

7 January 2021

Trends in antifungal susceptibility among Candida sp. Urinary isolates from 1994 and 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900214-0

7 January 2021

Nosocomial bloodstream infections in United States hospitals: a three-year analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900214-0

7 January 2021

Epidemiology of nosocomial fungal infections, with emphasis on Candida species

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900214-0

7 January 2021

Fungemia in a university hospital 1984-1988. Clinical and mycological characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900214-0

7 January 2021

The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900214-0

7 January 2021

Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900214-0

7 January 2021

National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathog

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900214-0

7 January 2021

Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900214-0

7 January 2021

National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900214-0

7 January 2021

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900214-0

7 January 2021

Resistance of Candida species to fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900214-0

7 January 2021

Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900214-0

7 January 2021

10.1016/S0732-8893(01)00214-0

Identifiers

DOI

1 reference

25 November 2017

1 reference